<DOC>
	<DOC>NCT01298440</DOC>
	<brief_summary>Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.</brief_summary>
	<brief_title>Bevacizumab Effect on Blood Velocity</brief_title>
	<detailed_description>The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.</detailed_description>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization, Pathologic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients with CNV receiving Bevacizumab intravitreal injection Candidates in whom the retina could not be seen clearly because of media opacity or a poorly dilating pupil</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>